Trusted by leading healthcare providers worldwide
.png)
The global standard in brain imaging AI
Longitudinal brain MRI monitoring is crucial for timely diagnoses and life-changing therapeutic decisions - but tracking subtle changes can be challenging and time-consuming.
The AI-driven, validated, and FDA-cleared icobrain solutions assist radiologists and neurologists with comparing and quantifying brain MRI scans over time.
Disease-specific solutions that impact outcomes
.png)
.png)
.png)
.png)
.png)
.png)
.png)
Precision and personalized medicine are becoming the standard of care quickly in neurology. As brain MRI scans are a crucial part of the diagnosis and monitoring in neurology, the quantitative analysis of the icometrix’ AI-software together with the radiological reading are needed for a data-driven clinical decision-making in neurology
Precision and personalized medicine are becoming the standard of care quickly in neurology. As brain MRI scans are a crucial part of the diagnosis and monitoring in neurology, the quantitative analysis of the icometrix’ AI-software together with the radiological reading are needed for a data-driven clinical decision-making in neurology
Dr. Joseph Fritz
President of the American Society of Neuroimaging
Backed by evidence
9
FDA and CE-marked solutions
#1
Validated AI solution for multiple sclerosis
>250
Scientific articles
published
40%
Increase in radiological reading speed
.png)
.png)
Fully integrated
and secure
What we often miss in following MS patients is subtle changes that take place over the course of many years. If you are not ordering icobrain for your MS patients, you may be leaving important information on the table.
What we often miss in following MS patients is subtle changes that take place over the course of many years. If you are not ordering icobrain for your MS patients, you may be leaving important information on the table.
Tiron Pechet, MD
Assistant Medical Director at Shields Healthcare
FDA cleared,
CE Marked Solutions
7
Hospitals using
our platform
400+
Countries our technology
is being used
30+
Care Enhanced
for patients
7K
Backed by evidence.
Proven in practice
#1
Validated AI solution for multiple sclerosis
9
FDA cleared solutions
>250
Scientific articles published
Backed by evidence.
Proven in practice
2.5x
Faster detection of treatment failure
40%
Increase in radiological reading speed
150%
Increased detection of disease activity in MS
68%
outcome improvement when employing icobrain® vs drugs alone
28
Countries with regulatory clearance
12
Awards
Integrating with these platforms
Latest news
AI Ethics in Healthcare: Doing it Right
Wim Van Hecke - founder/CEO icometrix Artificial intelligence in healthcare is often portrayed as the counterpart of the human touch....
icometrix rebranded: Same mission, sharper focus, scaled impact
Wim Van Hecke founder/CEO icometrix 16 May 2025 With a great team, we worked on refreshing the icometrix branding. It was a wonderful...
Only at Rush: Smarter MS Care With AI Insights and a Personal Companion App
A new partnership is giving Rush patients more insights and information on their MRI scans than ever before, making it easier to...
Meet our experts here
ASNR
Philadelphia, PA
17 May 2025
-
21 May 2025
CMSC
Phoenix, AZ
28 May 2025
-
31 May 2025
HL7 FHIR DevDays
Amsterdam, Netherlands
3 June 2025
-
6 June 2025
EAN
Helsinki, Finland
21 June 2025
-
24 June 2025
INS
Dubrovnik, Croatia
28 June 2025
-
30 June 2025
AAIC
Toronto, Canada
27 July 2025
-
31 July 2025
.png)
ENRS
Stowe, VT
21 Aug 2025
-
24 Aug 2025
ESNR
Istanbul, Turkey
17 Sept 2025
-
21 Sept 2025
ACTRIMS
Barcelona, Spain
24 Sept 2025
-
26 Sept 2025
.png)
ASFNR
Austin, TX
27 Sept 2025
-
29 Sept 2025
